Brief: AN2 Therapeutics Reports First Quarter 2023 Financial Results And Recent Highlights
11/05/2023 22:37
May 11 (Reuters) - AN2 Therapeutics Inc ANTX.O :
* AN2 THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
AND RECENT HIGHLIGHTS
* AN2 THERAPEUTICS INC - CASH, CASH EQUIVALENTS AND
INVESTMENTS
TOTALED $88.5 MILLION AT MARCH 31
Source text for Eikon: ID:nBw79PxNya
Further company coverage: ANTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AN2 Therapeutics
See all newsBrief: AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(C)(4)
Brief: An2 Therapeutics Announces Extension Of Funding For Tuberculosis Research Collaboration With Gsk
AN2 Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
AN2 Therapeutics Q2 net loss widens on higher R&D costs
AN2 Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview